🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
3.060
-0.100 (-3.16%)
At close: Nov 20, 2026, 4:00 PM EST
3.040
-0.020 (-0.65%)
After-hours: Nov 20, 2026, 7:41 PM EST

BriaCell Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Aug - Jul.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Jul '26 Jul '25 Jul '24 Jul '23 Jul '22
27301314106101
Market Cap Growth
101.71%133.36%-6.05%-87.19%4.90%29.07%
Enterprise Value
67-0127757
Last Close Price
3.063.447.46112.871003.50975.00

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Jul '26 Jul '25 Jul '24 Jul '23 Jul '22
PB Ratio
1.641.920.74-5.08-28.189.82
P/TBV Ratio
1.651.840.72--10.05

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Jul '26 Jul '25 Jul '24 Jul '23 Jul '22
Net Debt / Equity Ratio
-1.32-1.32-1.030.325.63-3.97
Net Debt / EBITDA Ratio
0.570.570.660.030.912.69
Net Debt / FCF Ratio
0.710.710.630.040.903.29
Quick Ratio
2.572.574.490.2111.8043.64
Current Ratio
2.762.765.010.4914.9645.00
Return on Equity (ROE)
-214.79%-214.79%-362.56%--619.75%-141.25%
Return on Assets (ROA)
-154.34%-154.34%-191.21%-29.01%-58.22%-53.35%
Return on Capital Employed (ROCE)
-231.10%-231.10%-153.90%2097.70%-91.80%-36.70%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Jul '26 Jul '25 Jul '24 Jul '23 Jul '22
Earnings Yield
-222.64%-116.77%-205.42%-35.14%-19.08%-26.45%
FCF Yield
-107.27%-96.28%-219.93%-180.31%-22.31%-12.30%
Buyback Yield / Dilution
-1084.29%-1084.29%-285.70%-5.35%-0.81%-242.82%
SEC Filings: 10-K · 10-Q